We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put CombiMatrix Corporation's financial performance into perspective.
Oct 14, 2014
Data to be Presented at ASHG 2014 Show That Miscarriage Analysis by Chromosomal Microarray Yields a Successful Result in More Than 85% of Cases
Oct 7, 2014
CombiMatrix Reports Preliminary Growth in Prenatal Microarray Testing Volumes of 71% and 64% for the Third Quarter and Year-to-Date, Respectively
View all releases »